ANGELA LORE: Open Payments
NPI 1487920609 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 173 payments from 21 companies in 2025. Trend: 2023 $3,330 · 2024 $2,936 · 2025 $3,060
Food & beverage: $2,974Education: $86
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $495 |
| UCB, Inc. | 25 | $416 |
| Regeneron Healthcare Solutions, Inc. | 7 | $250 |
| Novartis Pharmaceuticals Corporation | 20 | $239 |
| Lilly USA, LLC | 9 | $223 |
| Galderma Laboratories, L.P. | 19 | $222 |
| Amgen Inc. | 12 | $181 |
| Janssen Biotech, Inc. | 7 | $167 |
| PFIZER INC. | 10 | $143 |
| REVANCE THERAPEUTICS, INC. | 1 | $116 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, NEMLUVIO, COSENTYX, OTEZLA, TREMFYA, CIBINQO.
Industry payments across NY — which companies pay providers there.
